Cannabinoid has no impact on spasticity associated with MS

Cannabinoid  has no impact on spasticity associated with MS

In a report published in the scientific journal Movement Disorders, Vol. 17, No. 1.2002, Fox and associates.A Randomised, Double-Blind, Placebo-Controlled crossover study designed to see whether Nabilone would be effective in the treatment of muscle spasm (dystonia) associated with multiple sclerosis found no significant reduction in dystonia following treatment with nabilone”
Though the researchers seemed to have expected more favorable results, these results are consistent with a controlled, double-blind study done in 1995 on balance and coordination of MS patients, using smoked Marijuana Although the participants claimed to have relief from symptoms, high tech monitoring equipment showed that smoking marijuana actually made it worse.

Source:Fox And Associates published in scientific journal Movement Disorders vol 17 Nov 2002

Back to top of page

Powered by WordPress